FC
INSM icon

Fairscale Capital’s Insmed INSM Stock Holding History

Fairscale Capital’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.05K Hold
37
– – ﹤0.01% 328
2025
Q4 		$6.44K Hold
37
– – ﹤0.01% 318
2025
Q3 		$5.33K Hold
37
– – ﹤0.01% 356
2025
Q2 		$3.97K Buy
+37
New +$2.83K ﹤0.01% 367

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Fairscale Capital's INSM Position: Q1 2026 in Review

Fairscale Capital held its Insmed (INSM) position steady in Q1 2026 at 37 shares worth $6.05K. The position accounts for ﹤0.01% of the portfolio, ranked #328.

Fairscale Capital first reported a position in INSM in Q2 2025 and has held it in 4 quarters since. The position peaked at $6.44K in Q4 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Fairscale Capital held 37 shares of Insmed worth $6.05K as of Q1 2026.
  • Fairscale Capital left its Insmed share count unchanged in Q1 2026.
  • Insmed made up ﹤0.01% of Fairscale Capital's portfolio in Q1 2026, its #328 holding.
  • Fairscale Capital first reported a position in Insmed in Q2 2025 and has held it in 4 quarters since.
  • Fairscale Capital's Insmed position peaked at $6.44K in Q4 2025.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Fairscale Capital's 13F filing for Q1 2026, filed 11 May 2026.